The new trial makes mRNA vaccines personalized, taking an individual’s unique tumor cells. Seven out of the study’s eight ...

Scientists could soon develop personalized cancer vaccines.

Messenger RNA, or mRNA, vaccine technology burst onto the scene early in the COVID pandemic, leaving many people playing catch-up on the science behind the advance. Within the first six months of ...

The treatment staved off cancer for seven of eight patients with a condition where the odds are rarely that good.

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

Pancreatic cancer kills roughly nine out of every ten people diagnosed with it, most within five years. So when researchers ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...